Neurology (58 companies · 55 conditions)

Conditions

Multiple Sclerosis 10 Alzheimer's Disease 9 Major Depressive Disorder 9 Parkinson's Disease 9 Amyotrophic Lateral Sclerosis 8 Rare Myasthenia Gravis 8 Rare Bipolar Disorder 5 Duchenne Muscular Dystrophy 5 Rare Generalized Anxiety Disorder 5 Friedreich's Ataxia 4 Rare Frontotemporal Dementia 4 Rare Lewy Body Dementia 4 Epilepsy 3 Huntington's Disease 3 Rare Multiple System Atrophy 3 Rare Myotonic Dystrophy 3 Rare Post-Traumatic Stress Disorder 3 Schizophrenia 3 Substance Use Disorder 3 Attention Deficit Hyperactivity Disorder 2 Facioscapulohumeral Muscular Dystrophy 2 Rare Ischemic Stroke 2 Progressive Supranuclear Palsy 2 Rare Rett Syndrome 2 Rare Acute Pain 1 Aneurysmal Subarachnoid Hemorrhage 1 Angelman Syndrome 1 Rare Anorexia Nervosa 1 Ataxia-Telangiectasia 1 Rare Autism Spectrum Disorder 1 Charcot-Marie-Tooth Disease Type 2S 1 Rare Chronic Inflammatory Demyelinating Polyneuropathy 1 Rare CLN2 Batten Disease 1 Rare Cocaine Use Disorder 1 Delayed Sleep Phase Disorder 1 Fragile X Syndrome 1 Rare Giant Axonal Neuropathy 1 Rare GNE Myopathy 1 Rare Guillain-Barré Syndrome 1 Infantile Spasms 1 Rare Insomnia 1 Jet Lag Disorder 1 Limb-Girdle Muscular Dystrophy 1 Rare Migraine 1 Neuromyelitis Optica Spectrum Disorder 1 Rare Non-24-Hour Sleep-Wake Disorder 1 Non-Fluent Variant Primary Progressive Aphasia 1 Rare Postherpetic Neuralgia 1 Smith-Magenis Syndrome 1 Rare Spinal and Bulbar Muscular Atrophy 1 Rare Spinal Bulbar Muscular Atrophy 1 Rare Spinal Cord Injury 1 Stiff Person Syndrome 1 Rare Tuberous Sclerosis Complex 1 Rare X-Linked Adrenoleukodystrophy 1 Rare

Companies

Ticker	Company	Therapeutic areas	In Neurology	Lead stage	Programs
ACIU	AC Immune	Neurology Rare	10	Phase 3	11
ABOS	Acumen Pharmaceuticals	Neurology	4	Phase 2	4
ATHE	Alterity Therapeutics	Neurology Rare	2	Phase 3	2
ALT	Altimmune	GI/HepatologyMetabolic+1	1	Phase 2	3
AMLX	Amylyx Pharmaceuticals	MetabolicNeurology Rare	1	Phase 3	5
ANNX	Annexon	HematologyNeurology+2 Rare	3	NDA Submitted	6
ARVN	Arvinas	NeurologyOncology Rare	4	Approved	15
ATAI	Atai Beckley	Neurology	5	Phase 3	5
AUTL	Autolus Therapeutics	HematologyImmunology+3 Rare	1	Approved	12
CABA	Cabaletta Bio	DermatologyImmunology+2 Rare	1	Phase 1	8
CAPR	Capricor Therapeutics	Neurology Rare	1	NDA Submitted	1
RNAC	Cartesian Therapeutics	ImmunologyNeurology+1 Rare	1	Phase 3	4
CRVO	CervoMed	Neurology Rare	5	Phase 3	5
CING	Cingulate	Neurology	1	NDA Submitted	1
CLNN	Clene	Neurology Rare	3	NDA Submitted	5
CGTX	Cognition Therapeutics	Neurology	2	Phase 2	2
CMPS	COMPASS Pathways	Neurology	3	NDA Submitted	3
HELP	Cybin	Neurology	3	Phase 3	3
CYDY	CytoDyn	NeurologyOncology	1	Phase 2	3
DFTX	Definium Therapeutics	Neurology	4	Phase 3	4
DYN	Dyne Therapeutics	MetabolicNeurology Rare	7	NDA Submitted	10
EVMN	Evommune	DermatologyImmunology+1	1	Phase 2	6
GANX	Gain Therapeutics	MetabolicNeurology Rare	4	Phase 2	5
GHRS	GH Research	NeurologyWomen's Health	3	Phase 2	4
GRCE	Grace Therapeutics	Neurology Rare	3	NDA Submitted	3
IMUX	Immunic	GI/HepatologyNeurology	2	Phase 3	4
IMVT	Immunovant	ImmunologyNeurology Rare	2	Phase 2	6
IXHL	Incannex Healthcare	ImmunologyNeurology+1	1	Phase 2	3
KYTX	Kyverna Therapeutics	ImmunologyNeurology+1 Rare	3	NDA Submitted	7
LRMR	Larimar Therapeutics	Neurology Rare	1	NDA Submitted	1
LXEO	Lexeo Therapeutics	CardiovascularNeurology Rare	5	Phase 1	8
LGVN	Longeveron	CardiovascularMetabolic+1 Rare	1	Phase 2	4
NGEN	NervGen Pharma	Neurology	3	Phase 1	4
NGNE	Neurogene	Neurology Rare	1	Phase 3	1
NKTX	Nkarta	ImmunologyNeurology+1 Rare	1	Phase 1	7
NRXP	NRX Pharmaceuticals	Neurology	5	NDA Submitted	5
NRIX	Nurix Therapeutics	ImmunologyNeurology+1	1	Phase 2	15
OCS	Oculis Holding	NeurologyOphthalmology	1	Phase 3	5
OMER	Omeros	HematologyNeurology+2 Rare	2	NDA Submitted	7
OVID	Ovid Therapeutics	Neurology Rare	3	Phase 1	6
KTTA	Pasithea Therapeutics	NeurologyOncology Rare	2	Phase 1	4
PEPG	PepGen	Neurology Rare	1	Phase 2	1
PMN	ProMIS Neurosciences	Neurology Rare	6	Phase 1	6
RVPH	Reviva Pharmaceuticals	CardiovascularDermatology+2 Rare	6	Phase 3	10
SRPT	Sarepta Therapeutics	Neurology Rare	10	Approved	10
SLDB	Solid Biosciences	CardiovascularNeurology Rare	2	Phase 3	6
TSHA	Taysha Gene Therapies	Neurology Rare	3	Phase 3	4
TGTX	Tg Therapeutics	Neurology Rare	4	Approved	4
RARE	Ultragenyx Pharmaceutical	CardiovascularGI/Hepatology+2 Rare	2	Approved	12
QURE	uniQure	HematologyMetabolic+1 Rare	4	Approved	6
VNDA	Vanda Pharmaceuticals	CardiovascularDermatology+6 Rare	14	Approved	26
VKTX	Viking Therapeutics	GI/HepatologyMetabolic+1 Rare	1	Phase 3	9
VOR	Vor Biopharma	ImmunologyNeurology Rare	1	Phase 3	4
VYGR	Voyager Therapeutics	MetabolicNeurology Rare	6	Phase 1	7
WVE	Wave Life Sciences	MetabolicNeurology+1 Rare	2	Phase 2	5
XNCR	Xencor	HematologyImmunology+4 Rare	3	Approved	30
XENE	Xenon Pharmaceuticals	Neurology	6	Phase 3	6
ZBIO	Zenas BioPharma	DermatologyImmunology+1 Rare	3	NDA Submitted	11